|
Moderna aims for Fall release for omicron, variant-specific COVID-19 vaccine boosters |
mike kraft |
Group Post |
05/02/22 |
|
Moderna and Pfizer’s COVID-19 vaccine candidates require ultra-low temperatures, raising questions about storage, distribution |
mike kraft |
Group Post |
08/27/20 |
|
Moderna applies for full FDA approval for its COVID-19 vaccine |
mike kraft |
Group Post |
06/01/21 |
|
Moderna asks FDA to authorize 5 additional doses per Covid vaccine vial to speed distribution, source tells CNBC |
mike kraft |
Group Post |
02/02/21 |
|
Moderna asks FDA to authorize its updated Covid booster shot |
mike kraft |
Group Post |
08/23/22 |
|
Moderna asks FDA to clear COVID-19 vaccine for adolescents |
mike kraft |
Group Post |
06/10/21 |
|
Moderna awarded $176 million in USG funding to produce bird flu vaccine |
mike kraft |
Group Post |
07/02/24 |
|
Moderna begins phase 3 clinical trial of combo flu, COVID vaccine |
mike kraft |
Group Post |
10/25/23 |
|
Moderna begins study of COVID-19 vaccine in adolescents |
mike kraft |
Group Post |
12/10/20 |
|
Moderna begins study of COVID-19 vaccine in young children |
mike kraft |
Group Post |
03/16/21 |
|
Moderna CEO Cautions That COVID Vaccine Is 'Not a Silver Bullet' to End Pandemic |
mike kraft |
Group Post |
11/20/20 |
|
Moderna CEO in talks with China to supply COVID vaccines |
mike kraft |
Group Post |
01/18/23 |
|
Moderna CEO predicts that not everyone will need an annual COVID booster |
mike kraft |
Group Post |
10/17/22 |
|
Moderna CEO says it'll take months to develop, ship coronavirus vaccine targeting omicron variant |
mike kraft |
Group Post |
11/29/21 |
|
Moderna combination Covid, flu vaccine moves to final stage trial after positive data |
mike kraft |
Group Post |
10/04/23 |
|
Moderna completes FDA data submission for use of COVID shot in adolescents, kids |
mike kraft |
Group Post |
05/12/22 |
|
Moderna coronavirus vaccine shows 'promising' safety and immune response results in published Phase 1 study, but more research is needed |
mike kraft |
Group Post |
07/14/20 |
|
Moderna COVID vaccine safe, comparably effective in preschoolers ---clinical trial |
mike kraft |
Group Post |
10/20/22 |
|
Moderna Covid-19 vaccine is safe and appears effective in adolescents --company announcement |
mike kraft |
Group Post |
05/25/21 |
|
Moderna developing booster shot for coronavirus variants, boosts production target |
mike kraft |
Group Post |
02/24/21 |
|
Moderna files with FDA for emergency use of second Covid-19 booster shot |
mike kraft |
Group Post |
03/18/22 |
|
Moderna has been supplying vaccines to richer countries, keeping poor nations waiting. |
mike kraft |
Group Post |
10/11/21 |
|
Moderna moving ahead with two Omicron vaccine candidates against newer variants |
mike kraft |
Group Post |
07/11/22 |
|
Moderna plans to build vaccine plant in Africa |
mike kraft |
Group Post |
10/07/21 |
|
Moderna Plans to Expand Production to Make Covid-19 Vaccine Boosters, Supply More Countries |
mike kraft |
Group Post |
06/21/21 |
|
Moderna reported close to U.S. deal to make vaccines for Ebola, biological threats |
mike kraft |
Group Post |
10/26/22 |
|
Moderna reported to charge $130 for Covid vaccine dose, Senator Sanders calls the charges outrageous |
mike kraft |
Group Post |
01/10/23 |
|
Moderna reports higher immune response for next-generation COVID vaccine |
mike kraft |
Group Post |
03/29/24 |
|
Moderna reports it Omicron shots shows better immune response than original COVID vaccine |
mike kraft |
Group Post |
11/14/22 |
|
Moderna says Covid vaccine has fewer breakthrough cases than Pfizer’s, but higher myocarditis rates in young men |
mike kraft |
Group Post |
11/11/21 |
|
Moderna says COVID-19 vaccine 96 percent effective in teens |
mike kraft |
Group Post |
05/06/21 |
|
Moderna says COVID-19 vaccine performed well in a small lab study against delta variant |
mike kraft |
Group Post |
06/29/21 |
|
Moderna says dual variant booster with Beta more effective vs Omicron than current shot |
FNUOvviyaa |
Group Post |
04/19/22 |
|
Moderna says FDA needs more time to review its Covid vaccine for teens |
mike kraft |
Group Post |
11/01/21 |
|
Moderna says initial booster data shows good results on omicron |
mike kraft |
Group Post |
12/20/21 |
|
Moderna says it has no plans to share its COVID-19 vaccine formula but will scale up production |
mike kraft |
Group Post |
10/11/21 |
|
Moderna says its revised flu shot succeeds against all 4 strains of the virus |
mike kraft |
Group Post |
09/13/23 |
|
Moderna says its booster candidate shows strong response against Omicron subvariants |
mike kraft |
Group Post |
06/22/22 |
|
Moderna says its coronavirus vaccine shows promising results in small trial of elderly patients |
mike kraft |
Group Post |
08/26/20 |
|
Moderna says its Covid vaccine has strong results in children ages 6 to 11 |
mike kraft |
Group Post |
10/27/21 |
|
Moderna says its COVID-19 vaccine can be stored at refrigerator temperatures for 3 months |
mike kraft |
Group Post |
04/29/21 |
|
Moderna says its COVID-19 vaccine protective, safe in young children |
mike kraft |
Group Post |
10/25/21 |
|
Moderna says its Covid-flu combination vaccine shows positive results in late-stage trial |
mike kraft |
Group Post |
06/10/24 |
|
Moderna says its Omicron booster response stays high through 3 months |
mike kraft |
Group Post |
10/19/22 |
|
Moderna says it’s working on Covid booster shot for variant in South Africa, says current vaccine provides some protection |
mike kraft |
Group Post |
01/25/21 |
|
Moderna says new Covid vaccine showed stronger immune response than current version --study |
mike kraft |
Group Post |
03/26/24 |
|
Moderna says Omicron represents a "significant potential risk" to vaccine and natural-induced immunity |
mike kraft |
Group Post |
11/26/21 |
|
Moderna says updated COVID shot boosts omicron protection |
FNUOvviyaa |
Group Post |
06/08/22 |
|
Moderna seeks EU authorization for COVID-19 vaccine in children 6-11 |
mike kraft |
Group Post |
11/09/21 |
|
Moderna seeks FDA approval for COVID shots for youngest children |
mike kraft |
Group Post |
04/28/22 |
Recent Comments